# Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease

> **NCT01937221** · — · COMPLETED · sponsor: **Duke University** · enrollment: 60 (estimated)

## Conditions studied

- Mild Cognitive Impairment
- Mild to Moderate Cognitive Impairment

## Interventions

- **OTHER:** spectral-domain optical coherence tomography (SD-OCT)

## Key facts

- **NCT ID:** NCT01937221
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-01-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01937221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01937221, "Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01937221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*